About Aibili

AIBILI – Association for Innovation and Biomedical Research on Light and Image is a Research Technology Organisation in the health area dedicated to the development and clinical research of new products for medical therapy and diagnostic imaging. It is a private non-profit organisation, founded in 1989, established to support translational research and technology transfer in the health area. In 2019 AIBILI celebrates its 30th anniversary.

  • Performance of clinical studies
  • Planning, coordination, monitoring of clinical research activities
  • Health technology assessment
  • Grading of eye exams
  • Research and development in new technologies for medicine in the areas of imaging, optics and photobiology
  • Preclinical studies of new molecules with potential medical use data centre activities
  • Data centre activities (also Certified by ECRIN)

Clinical trials are performed in accordance with ICH Guidelines for Good Clinical Practice (GCP), European and national applicable legislations and regulations.

AIBILI is located at the Health Campus of Coimbra University since 1994 and has its own building with 15.296 sq. feet and state-of-the-art equipment. Regarding human resources it has a permanent staff of 45 including medical doctors, researchers, engineers, pharmacologists, technicians, trial and project managers, regulatory affairs, trial coordinators and administrative personnel. Another 60 individuals collaborate regularly on a part-time basis involved mainly in research activities.

  • EVICR.net Coordinating Centre
  • Coimbra Coordinating Centre for Clinical Research (4C)
  • Clinical Trial Centre (CEC)
  • Centre for New Technologies in Medicine (CNTM)
  • Coimbra Ophthalmology Reading Centre (CORC)
  • Centre for Health Technology Assessment and Drug Research (CHAD)
  • Administrative Services (SA)
  • Quality Management Unit (UGQ)
  • Translational Research and Technology Transfer Unit (UTT)
  • Information Technology Unit (IT)
  • Data Centre (DC).
  • Development and Coordination of Industry-Driven and Investigator Initiated Clinical Trials
  • Data Centre
  • Performance of Clinical Studies in ophthalmology and neurology (phase I, II, III and IV)
  • Preclinical studies of new molecules with potential medical use
  • Development of new technologies – ophthalmology imaging
  • Reading Centre: Grading of color fundus photographs, OCT images of the retina and functional evaluations of the retina using mfERG
  • Pharmacotherapeutic and Pharmacoeconomic studies
  • Pharmacovigilance
    • Universidade de Coimbra
    • FLAD - Fundação Luso-Americana para o Desenvolvimento
    • Fundação Champalimaud
    • IAPMEI - Instituto de Apoio às Pequenas e Médias Empresas e à Inovação
    • José Cotta - EMS, S.A.
    • José Cunha-Vaz
    • Laboratório EDOL - Produtos Farmacêuticos, S.A.
    • Biofísica da Faculdade de Medicina da Universidade de Coimbra
    • Serviço de Dermatologia dos Hospitais da Universidade de Coimbra
    • Farmacologia da Faculdade de Medicina da Universidade de Coimbra
    • SUCH - Serviço de Utilização Comum dos Hospitais
    • Alcon Portugal - Prod. e Equip. Oftalmológicos, Lda.
    • BIAL - Portela & Cª., S.A.
    • Centro de Oftalmologia da Universidade de Coimbra
    • Conceição Lobo
    • Francisco Batel Marques
    • Hospital Cuf Coimbra / José de Mello Saúde
    • Laboratórios Pfizer, Lda.
    • Novartis Farma, S.A.
    • José Cunha-Vaz, President
    • Conceição Lobo (Rep. José Cotta - EMS, SA), Vice-President
    • Tice Macedo (Rep. BIAL - Portela & Cª, SA)
    • António Parreira (Rep. Fundação Champalimaud)
    • Gonçalo Pimpão (Rep. Laboratório EDOL - Produtos Farmacêuticos, S.A.)
    • Américo Figueiredo (Rep. Serviço de Dermatologia do Centro Hospitalar e Universitário de Coimbra)
    • Francisco Batel Marques
CHAMPALIMOUD FOUNDATION www.fchampalimaud.org

The Champalimaud Foundation recognized in 2010 AIBILI as one of its C-TRACERs – Champalimaud Translational Centres for Eye Research.

The C-TRACERs focus on translational eye research as it strives to further the knowledge of vision in such a way that it can be readily applied to the patient.The C-TRACER Network is formed by Centres in Portugal, India and Brazil. The India C-TRACER is the L. V. Prasad Eye Institute in Hyderabad and the Brazilian C-TRACER is the Institute for Vision at the Federal University of S. Paulo at S. Paulo.

Ongoing joint research activities bringing together these institutions and the Department of Ophthalmology of the University Hospital of Coimbra are focused on predicting progression of diabetic retinopathy, stem-cell treatment of eye diseases and teleophthalmology and this way translating basic research to clinical research and enhancing the adoption of best practices in the community.

EVICR.net has a Coordinating Centre, AIBILI, who is responsible for the management of the Network, coordination of multinational clinical research studies as well as developing training activities.

The EVICR.net is a network of European Ophthalmological Clinical Research Centres, dedicated to perform multinational clinical research in ophthalmology with the highest standards of quality, following the European and International Directives for Clinical Research according to harmonized SOPs.

Health Cluster Portugal http://www.healthportugal.com/

AIBILI is member of the Health Cluster Portugal (HCP) whose main objective is the promotion and implementation of initiatives and activities leading to the consolidation of a national cluster for competitiveness, innovation and technology in the health area. More information: www.healthportugal.com

AIBILI is an Interface Centre in the Health Sector of the National Technology Network. This recognition identifies AIBILI as the technology transfer centre acting as the facilitating partner between scientific institutions, enterprises and industry in order to bring novel products to the market.

More information: http://www.programainterface.pt/pt

EATRIS is a client driven, non-profit organization comprising European academic centers of excellence in translational research. EATRIS partner institutes support in bringing innovative ideas for novel preventive, diagnostic or therapeutic products towards first in human application and on to clinical proof of concept. EATRIS partner institutes provide services and expertise in the following areas: Advanced therapy medicinal products and biologics; Biomarkers; Imaging and tracing; Small molecules; and Vaccines.

AIBILI, with capacities for the Biomarkers and Imaging platforms, has been accepted as a member of the EATRIS Portuguese-Hub, led by INFARMED, and is in the process of integrating this European Network.

ECRIN-ERIC is a network dedicated to improving the health of patients and citizens across the world through clinical research. ECRIN-ERIC supports multinational collaboration in clinical research, acting through correspondents hosted in national clinical research hubs and networks. ECRIN is based on the connection of coordinating centres for national networks of clinical research centres and clinical trials units, able to provide support and services to multinational clinical research.

AIBILI, as Coordinating Centre of EVICR.net, a disease oriented network in ophthalmology for clinical research, is an Affiliate Partner of ECRIN-ERIC. Thus, EVICR.net serves as a resource to ECRIN-ERIC in the area of vision and ophthalmology multinational clinical research, particularly by providing scientific and medical expertise, access to patients and research capacity.

PtCRIN is the national clinical research network aiming to facilitate and improve quality in clinical research and to increase national and international research collaboration for the benefit of patients, citizens and the healthcare system. PtCRIN is the Portuguese member of ECRIN-ERIC.

AIBILI is a founding member of the PtCRIN.


Azinhaga Sta. Comba, Celas
3000-548 Coimbra

Portugal Geographical coordinates:
40º 13' 06,24" N
8º 24' 54,83" O

Telephone: +351 239 480100
Fax: +351 239 480117

mail: aibili@aibili.pt